follicular
cell
antivir
effect
chronic
viru
infect
role
cell
dengu
viru
infect
remain
poorli
understood
object
studi
conduct
analyz
detail
dynam
chang
function
properti
circul
follicular
cell
explor
effect
infect
method
circul
follicular
cell
cytokin
analyz
flow
cytometri
patient
differ
day
infect
cell
isol
purifi
patient
stimul
peptid
tcr
stimul
cultiv
multipl
paramet
test
result
cell
emerg
infect
high
express
correl
reduct
rna
viral
load
cell
neg
associ
diseas
progress
serum
ifng
level
increas
late
cours
infect
cell
patient
exhibit
increas
cytotox
ifng
secret
conclus
cell
could
play
protect
role
dengu
pathogenesi
may
novel
strategi
control
infect
vaccin
develop
dengu
fever
preval
mosquitoborn
viral
diseas
caus
four
close
relat
serotyp
dengu
virus
denv
affect
human
tropic
subtrop
region
worldwid
bhatt
et
al
present
infect
rang
asymptomat
infect
sever
form
diseas
dengu
hemorrhag
fever
dhf
dengu
shock
syndrom
dss
guo
et
al
howev
satisfactori
vaccin
mean
predict
diseas
sever
earli
stage
denv
patient
collin
barrett
viral
host
factor
includ
host
immun
function
seem
relat
diseas
sever
duangchinda
et
rothman
weiskopf
sett
howev
immunolog
process
denv
infect
yet
complet
defin
understand
mechan
regul
balanc
immunemedi
protect
pathogenesi
denv
infect
critic
step
toward
develop
safe
effect
denv
therapeut
vaccin
well
known
cell
play
role
antivir
immun
human
viral
infect
de
alwi
et
al
elong
ngono
et
al
yauch
et
al
zellweg
et
al
zellweg
et
al
respons
infect
antigenspecif
cell
prime
cell
zone
secondari
lymphoid
organ
differenti
effector
cytotox
cell
elimin
infect
cell
mueller
et
al
recent
subset
cell
high
cxc
chemokin
receptor
type
express
shown
possess
antivir
properti
chronic
viru
infect
cell
gener
display
exhaust
phenotyp
cross
et
al
et
al
leong
et
al
quigley
et
al
addit
cell
exhibit
potent
proinflammatori
function
cell
chronic
siv
infect
mylvaganam
et
al
recent
studi
report
cell
chronic
lcmv
hiv
infect
select
enter
bcell
follicl
erad
infect
follicular
helper
cell
tfh
b
cell
exhibit
potent
cytotox
demonstr
synergist
therapeut
potenti
combin
neutral
et
al
quigley
et
al
upon
adopt
transfer
mice
receiv
cell
present
significantli
lower
viral
load
mice
receiv
cell
tcell
dysfunct
chronic
viral
infect
associ
express
inhibitori
receptor
trautmann
et
al
trautmann
et
al
velu
et
al
zhang
et
al
present
express
cell
viral
infect
remain
controversi
studi
im
et
al
petrova
et
al
report
high
express
cell
compar
cell
chronic
viral
infect
wherea
et
al
et
al
report
cell
express
significantli
lower
level
inhibitori
molecul
higher
level
proinflammatori
cytokin
ifng
howev
studi
cell
patient
still
lack
moreov
whether
cell
contribut
antivir
immun
infect
remain
unknown
better
understand
cell
respons
role
protect
immunopatholog
examin
dynam
chang
function
properti
cell
infect
blood
patient
suspect
dengu
fever
obtain
present
zhejiang
provinc
peopl
hospit
due
outbreak
zhejiang
hangzhou
china
diagnosi
confirm
sampl
test
posit
rna
revers
transcriptasepolymeras
chain
reaction
rtpcr
sampl
screen
serolog
test
includ
herp
simplex
viru
rubella
viru
cytomegaloviru
toxoplasma
rotaviru
coxsacki
viru
mycoplasma
chlamydia
hepat
b
c
exclud
viru
bacteria
infect
also
enrol
healthi
individu
hi
asymptomat
neg
denv
igm
rna
characterist
patient
hi
depict
tabl
heparin
peripher
blood
sampl
collect
diagnosi
subsequ
day
day
diagnosi
longitudin
studi
patient
gave
inform
consent
sampl
analysi
accord
declar
helsinki
studi
approv
zhejiang
provinc
peopl
hospit
review
board
routin
clinic
index
includ
white
blood
cell
wbc
lymphocyt
lym
platelet
plt
count
hematocrit
hct
determin
peripher
whole
blood
glutamicpyruv
transaminas
alt
aspart
transaminas
ast
lactat
dehydrogenas
ldh
creatin
kinas
ck
creatinin
cr
urea
detect
serum
sampl
isol
clot
blood
centrifug
follow
monoclon
antibodi
use
surfac
immunophenotyp
assay
clone
bd
bioscienc
usa
clone
bd
bioscienc
usa
clone
bd
bioscienc
usa
clone
beckman
coulter
usa
cell
incub
antibodi
min
c
dark
wash
pb
isotyp
antibodi
control
use
procedur
stain
cell
analyz
use
facscantoii
flow
cytomet
facsdiva
softwar
becton
dickinson
spark
md
strategi
shown
figur
cytokin
concentr
serum
measur
bd
cytometr
bead
array
cba
human
cytokin
kit
bd
bioscienc
san
jose
usa
follow
manufactur
instruct
function
analys
cell
cell
isol
peripher
blood
ficollhypaqu
densiti
gradient
centrifug
combin
human
cell
enrich
kit
thermo
scientif
accord
manufactur
protocol
efficaci
isol
routin
plate
cellswel
ubottom
plate
cell
stimul
mgml
peptid
santa
usa
tcr
stimul
mgml
plu
mgml
mgml
brefeldin
clone
ebiosci
waltham
usa
last
h
cell
stimul
pib
pma
ionomycin
brefeldin
use
posit
control
wherea
unstimul
cell
use
neg
control
cell
collect
wash
label
clone
bd
bioscienc
usa
clone
bd
bioscienc
usa
cell
fix
permeabil
use
intreprep
permeabil
reagent
kit
beckman
coulter
miami
fl
usa
incub
min
c
specif
antibodi
clone
ebiosci
waltham
usa
ifngapc
clone
ebiosci
waltham
usa
clone
ebiosci
waltham
usa
clone
bd
bioscienc
franklin
lake
nj
usa
perforinalexa
clone
ebiosci
waltham
usa
flow
cytometr
acquisit
perform
facscanto
ii
instrument
facsdiva
softwar
bd
bioscienc
usa
infect
confirm
rtpcr
previous
describ
lai
et
al
pang
et
al
total
cellular
rna
isol
ml
whole
blood
obtain
patient
use
trizol
ls
reagent
accord
manufactur
protocol
invitrogen
ng
rna
use
estim
denv
viremia
taqman
one
step
rtpcr
describ
previous
peripher
blood
denv
rna
viral
load
determin
use
rtpcr
crossov
valu
ct
detect
limit
assay
copiesml
statist
analysi
perform
graphpad
prism
softwar
statist
test
data
analysi
includ
mann
whitney
utest
correl
variabl
determin
use
spearman
correl
coeffici
quantit
data
present
mean
ae
standard
deviat
sd
p
p
p
consid
statist
signific
first
evalu
level
circul
follicular
cell
patient
frequenc
number
cell
low
patient
figur
b
compar
hi
remain
constant
howev
frequenc
number
increas
higher
observ
hi
figur
investig
level
high
cell
patient
observ
higher
frequenc
high
cell
higher
frequenc
number
high
cell
hi
figur
sinc
tcell
increas
late
cours
infect
phenomenon
lead
us
question
whether
cell
associ
rna
viral
load
patient
rna
viral
load
evalu
differ
day
infectiona
expect
higher
viralload
observ
shown
figur
decreas
thereaft
remark
rna
viral
load
neg
correl
number
circul
tcell
figur
result
impli
cell
may
play
role
control
replic
acut
phase
dengu
figur
highli
express
cell
neg
associ
diseas
progress
repres
express
cell
one
patient
b
mfi
cell
patient
c
repres
flow
cytometr
dot
plot
gate
cell
one
hi
one
patient
differ
day
diagnosi
frequenc
left
number
right
cell
patient
differ
day
diagnosi
e
comparison
frequenc
left
number
right
cell
patient
without
kidney
injuri
f
comparison
frequenc
left
number
right
cell
two
group
categor
platelet
count
g
comparison
frequenc
left
number
right
cell
patient
without
liver
injuri
h
comparison
frequenc
left
number
right
cell
patient
without
myocardi
injuri
ki
kidney
injuri
li
liver
injuri
mi
myocardi
injuri
plt
platelet
highli
express
cell
neg
associ
diseas
progress
import
function
marker
highli
express
follicular
helper
cell
banga
et
al
xu
et
al
howev
function
follicular
cell
remain
controversi
thu
analyz
express
cell
compar
cell
cell
exhibit
enhanc
express
figur
b
herein
investig
frequenc
number
cell
patient
statist
analysi
demonstr
higher
frequenc
cell
differ
day
diagnosi
higher
number
cell
patient
hi
figur
data
lead
us
question
whether
cell
associ
diseas
progress
patient
clinic
set
patient
develop
kidney
injuri
thrombocytopenia
subsequ
compar
patient
group
accord
kidney
injuri
level
cell
patient
kidney
injuri
significantli
higher
without
kidney
injuri
figur
frequenc
cell
higher
patient
lower
platelet
count
ml
normal
platelet
count
ml
figur
moreov
compar
cell
clinic
characterist
includ
liver
injuri
myocardi
damag
figur
h
found
signific
correl
cell
clinic
characterist
find
suggest
cell
could
neg
associ
diseas
progress
serum
ifng
increas
late
cours
infect
know
cytokin
play
crucial
role
pathogenesi
dengu
lead
sever
dengu
diseas
oliveira
et
al
pandey
et
al
understand
kinet
immun
respons
respect
secret
cytokin
detect
serum
cytokin
level
patient
differ
day
diagnosi
serum
level
low
patient
compar
hi
figur
b
f
ifng
level
increas
patient
higher
hi
figur
also
evalu
result
limit
detect
assay
pgml
studi
demonstr
primari
denv
infect
elicit
polyfunct
effector
cell
express
ifng
perforin
thu
contribut
viral
clearanc
alter
et
al
perform
mechanist
studi
cell
respons
vitro
first
examin
whether
cell
capabl
mediat
cytotox
effect
cell
five
patient
five
hi
harvest
stimul
peptid
tcr
stimul
five
patient
examin
cell
present
higher
perforinand
cell
cell
patient
also
higher
perforinreleas
cell
hi
figur
next
examin
function
cell
secret
ifng
found
immedi
follow
isol
cell
demonstr
significantli
lower
level
ifng
secret
stimul
peptid
tcr
stimul
level
compar
patient
hi
figur
g
howev
cell
patient
stimul
produc
higher
level
ifng
compar
cell
figur
f
cell
patient
significantli
potent
ifng
secret
hi
figur
f
result
suggest
cell
potenti
degranul
cytokin
secret
infect
figur
serum
ifng
level
increas
late
cours
infect
cytokin
determin
cba
blood
serum
hi
patient
af
serum
ifng
level
figur
cell
patient
possess
increas
cytotox
high
capac
secret
ifng
cell
cell
patient
n
hi
n
stimul
h
peptid
tcr
stimul
live
cell
gate
stain
perforin
ifng
express
cell
examin
intracellular
stain
flow
cytometr
plot
perforin
ifng
express
cell
one
patient
statist
analysi
perforin
b
c
ifng
e
f
g
express
cell
follicular
cytotox
cell
shown
antivir
properti
chronic
viru
infect
cross
et
al
et
al
leong
et
al
quigley
et
al
liu
et
al
studi
found
circul
cell
especi
high
cell
emerg
later
cours
infect
may
relat
gradual
migrat
cell
lymph
node
peripheri
infect
importantli
peak
cell
correl
rna
reduct
suggest
protect
role
cell
control
replic
abnorm
express
cell
play
role
chronic
viral
infect
day
et
al
sharp
et
al
differ
opinion
regard
express
cell
chronic
viral
infect
found
high
express
cell
compar
cell
consist
find
im
et
al
petrova
et
al
addit
higher
level
cell
found
patient
interestingli
higher
level
cell
found
patient
kidney
injuri
lower
platelet
number
find
suggest
cell
could
neg
associ
diseas
progress
function
experi
demonstr
cell
potenti
degranul
cytokin
secret
infect
suggest
cell
may
protect
infect
larg
part
via
cytotox
effector
function
observ
partial
agreement
studi
perform
chronic
lcmvinfect
mice
follicular
lymphoma
show
cell
express
proinflammatori
cytokin
cell
et
al
eppi
et
al
investig
earli
immun
signatur
help
address
mechan
influenc
vivo
gener
antivir
cell
data
combin
recent
publish
studi
highlight
import
cell
underscor
need
develop
immunebas
strategi
capabl
gener
cell
vivo
mean
target
elimin
cell
know
cytokin
associ
sever
dengu
diseas
oliveira
et
al
pandey
et
al
eppi
et
al
tsai
et
al
studi
shown
high
level
dengu
infect
liver
section
elev
level
patient
sever
dengu
oliveira
et
al
pandey
et
al
consist
find
oliveira
et
al
pandey
et
al
floresmendoza
et
al
observ
high
level
ifng
late
cours
infect
although
gener
regard
antiinflammatori
cytokin
sever
studi
suggest
contribut
antitumor
immun
assist
expans
tumorresid
cell
emmerich
et
al
mumm
et
al
mice
coronavirusinduc
acut
enceph
cell
demonstr
potent
activ
cytolyt
activ
cell
suggest
might
improv
cell
surviv
activ
acut
inflamm
trandem
et
al
studi
also
observ
cell
patient
exhibit
high
secret
time
level
ifng
canon
cell
activ
marker
increas
would
expect
high
level
inou
et
al
jarnicki
et
al
combin
result
cell
might
contribut
control
infect
stimul
rather
suppress
conclus
demonstr
cell
emerg
infect
high
express
function
cytotox
respons
correl
rna
reduct
result
show
first
time
protect
role
cell
dengu
pathogenesi
indic
cell
repres
novel
strategi
control
infect
vaccin
develop
studi
partli
support
zhejiang
provinci
natur
scienc
fund
author
declar
conflict
interest
written
inform
consent
obtain
enrol
patient
healthi
individu
